Tag

Chlorthalidone

All articles tagged with #chlorthalidone

Thousands of Chlorthalidone BP Pills Recalled Over Dissolution Failures
health2 hours ago

Thousands of Chlorthalidone BP Pills Recalled Over Dissolution Failures

The FDA is recalling about 11,400 bottles of the 25 mg diuretic chlorthalidone after testing showed some lots failed dissolution specifications, potentially reducing effectiveness. The tablets were made by Inventia Healthcare Limited (Mumbai) and distributed nationwide by Rising Pharma Holdings; affected products include 100-count (NDC 64980-599-01, batch RISA24001, exp. 04/2027) and 1,000-count (NDC 64980-599-10, batch RISB24002, exp. 04/2027) bottles. The recall is Class II (moderate hazard), and the FDA has not issued patient-specific instructions yet; patients should check their labels and consult a doctor or pharmacist if they have recalled tablets.

Widespread recall of chlorthalidone BP tablets over dissolution issue
health1 day ago

Widespread recall of chlorthalidone BP tablets over dissolution issue

More than 11,000 bottles of the blood pressure medication Chlorthalidone Tablets USP, 25 mg, were recalled nationwide after a manufacturing issue caused dissolution failures. The recall involves both 100-count and 1,000-count bottles distributed in the United States by Rising Pharma Holdings Inc. of New Jersey; 11,460 bottles are included. Inventia Healthcare Limited initiated the voluntary recall on June 5. The FDA enforcement report notes the tablets may not dissolve as intended, and patients should consult their pharmacist or healthcare provider if they may have a recalled bottle; do not stop taking prescribed medication without medical advice.

Nationwide recall issued for common hypertension drug due to dissolution defect
nation-and-world1 day ago

Nationwide recall issued for common hypertension drug due to dissolution defect

More than 11,000 bottles of chlorthalidone tablets (25 mg) used to treat high blood pressure have been recalled nationwide after a manufacturing issue caused dissolution specifications to fail. Inventia Healthcare Limited initiated the voluntary recall on June 5, with 100-count bottles (Lot RISA24001) and 1,000-count bottles (Lot RISB24002) distributed in the U.S. by Rising Pharma Holdings Inc. The FDA has not yet assigned a recall classification, and no public press release had been issued; patients should contact their pharmacist or healthcare provider if they believe they have a recalled bottle and should not stop taking prescribed medication without medical advice.